Yongmei Zeng

Yongmei Zeng


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2019 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
YZYongmei Zeng
Yongmei Zeng
JZJiyong Zhang
Jiyong Zhang
GDGuoqing Dong
Guoqing Dong
PLPeihui Liu
Peihui Liu
FXFei Xiao
Fei Xiao
QWQianzhen Wu
Qianzhen Wu
The diagnosis of cow’s milk protein allergy(CMPA) may be easily misdiagnosed due to its lack of specific symptoms. Thus, experts have proposed the use of Cow’s milk-related symptom scores (CoMiSS) to predict CMPA. There has been no relevant report on the clinical application value of CoMiSS in Chinese children. This study aimed to evaluate the effect of CoMiSS in early identification of CMPA in Chinese infants. We calculated CoMiSS for 38 infants with suspected CMPA diagnosed in the pediatric gastroenterologic clinic in our hospital. After 4 weeks of dietary elimination and symptomatic improvement, these infants returned to our hospital to undergo oral food challenge (OFC). The ROC curve was used to determine the sensitivity and specificity of CoMiSS and evaluate the effect of CoMiSS in early identification of CMPA in Chinese infants. We didn’t determine the CoMiSS of presumed healthy infants as control group. Of 38 infants who underwent OFC testing, the average CoMiSS of infants with positive OFC testing was 7.4 ± 2.3, while the average CoMiSS of infants with negative OFC testing was 4.1 ± 1.6, and there was a significant difference between two groups(F = 2.13, P<0.05). The area under the ROC curve (AUC) of CoMiSS was 0.89, and the best diagnostic cut-off point was 5.5. The sensitivity of CoMiSS was 87.5%, while the specificity of CoMiSS was 78.6%. CoMiSS is a simple and operable method to screen for CMPA, though there may be a risk of under-diagnosis when CoMiSS≥12 is used as the criterion for early identification of CMPA in Chinese infants. More multi-center studies are needed to evaluate whether the factors such as bloody stool should be included in CoMiSS or CoMiSS≥6 can be used as the criterion for early identification of CMPA in Chinese infants.

1 February 2025 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
QSQin Sun
Qin Sun
JHJindou Hao
Jindou Hao
QZQixin Zhou
Qixin Zhou
YZYongmei Zeng
Yongmei Zeng
Background: Mycoplasma pneumoniae pneumonia (MPP) is a prevalent disease among children. Typically, macrolides are the first-line treatment for MPP in China. However, the number of cases resistant to macrolides has been rising, especially after the outbreak of the COVID-19 pandemic, which has further complicated the clinical management of macrolide-unresponsive Mycoplasma pneumoniae pneumonia (MUMPP) in children. Objective: This study examined the clinical characteristics of MUMPP and the effects of various treatments on children with MUMPP during March 2023 to February 2024 in southern China. Methods: We conducted a retrospective case–control study at a university-affiliated hospital in southern China. Patients were categorized based on their response to macrolide treatment into two groups: MUMPP and control group. The study included 549 pediatric patients. Of these, 297 were in the MUMPP group and 252 were in the control group. This categorization allowed us to compare clinical characteristics and laboratory indicators between the groups. The MUMPP group received one of the three treatments: combined antibiotics, additional steroids, or a switch to doxycycline. Subsequently, we analyzed differences in clinical outcomes, which included hospital stay, hospital cost, and recovery time. Results: No significant differences were found in gender or pre-admission disease duration between the MUMPP and control group (P> 0.05). However, subjects in MUMPP group was older, had longer fever durations, extended hospital stays, higher medical costs, and elevated levels of C-reactive protein, lactate dehydrogenase, IL-6, and γ-IFN. All of which showed statistically significant differences (P< 0.05). Within the MUMPP group, patients switched to doxycycline had the shortest hospital stay and recovery time, significantly differing from those in other treatment groups (P< 0.05). Conclusion: Children in the MUMPP group exhibited higher inflammatory indicators than the control group. The early adaptation of treatment strategies, particularly the switch to doxycycline, is associated with improved clinical outcomes.

23 December 2019 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
CCChengcong Chen
Chengcong Chen
YHYing Huang
Ying Huang
YZYongmei Zeng
Yongmei Zeng
XLXiyan Lu
Xiyan Lu
GDGuoqing Dong
Guoqing Dong
Background: The most significant manifestation of heart failure is exercise intolerance. This systematic review and meta-analysis was performed to investigate whether dipeptidyl peptidase-4 (DPP-4) inhibitors or glucagon-like peptide 1 receptor agonists (GLP-1 RAs), widely used anti-diabetic drugs, could improve exercise tolerance in heart failure patients with or without type 2 diabetes mellitus. Methods: An electronic search of PubMed, EMBASE and the Cochrane Library was carried out through March 8th, 2019, for eligible trials. Only randomized controlled studies were included. The primary outcome was exercise tolerance [6-min walk test (6MWT) and peak O2 consumption], and the secondary outcomes included quality of life (QoL), adverse events (AEs) and all-cause death. Result: After the literature was screened by two reviewers independently, four trials (659 patients) conducted with heart failure patients with or without type 2 diabetes met the eligibility criteria. The results suggested that targeting the DPP-4-GLP-1 pathway can improve exercise tolerance in heart failure patients [MD 24.88 (95% CI 5.45, 44.31), P = 0.01] without decreasing QoL [SMD -0.51 (95% CI -1.13, 0.10), P = 0.10]; additionally, targeting the DPP-4-GLP-1 pathway did not show signs of increasing the incidence of serious AEs or mortality. Conclusion: Our results suggest that DPP-4 inhibitors or GLP-1 RAs improve exercise tolerance in heart failure patients. Although the use of these drugs for heart failure has not been approved by any organization, they may be a better choice for type 2 diabetes mellitus patients with heart failure. Furthermore, as this pathway contributes to the improvement of exercise tolerance, it may be worth further investigation in exercise-intolerant patients with other diseases.

1 January 2020
Verified
Journal Article
Closed access
YZYongmei Zeng
Yongmei Zeng
SZShao-Ming Zhou
Shao-Ming Zhou
SWShao-Hua Wang
Shao-Hua Wang
FSFeng-Xuan Sui
Feng-Xuan Sui
WGWu-Hong Gao
Wu-Hong Gao
YZYong-Mei Zeng
Yong-Mei Zeng

15 March 2026
Verified
Journal Article
Closed access
WLWei-Yan Li
Wei-Yan Li
YZYongmei Zeng
Yongmei Zeng
JZJi-Yong Zhang
Ji-Yong Zhang
XLXi-Yan Lu
Xi-Yan Lu
WWWu-Jin Wang
Wu-Jin Wang
GDGuo-Qing Dong
Guo-Qing Dong

7 November 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JZJiyong Zhang
Jiyong Zhang
WLWeiyan Li
Weiyan Li
XQXiaoying Qiu
Xiaoying Qiu
YWYuanyuan Wang
Yuanyuan Wang
YZYongmei Zeng
Yongmei Zeng
Non-alcoholic fatty liver disease (NAFLD) is a prevalent condition strongly linked to obesity, diabetes, and metabolic syndrome. Its global incidence is steadily increasing, placing a significant health burden on both patients and society. This study aims to identify ferroptosis-related differentially expressed genes (DEGs) through bioinformatics analysis and to explore their roles in NAFLD. By comparing samples from NAFLD patients and healthy controls, we identified 1,770 significant DEGs, with 1,073 being upregulated and 697 downregulated. Pathway analysis revealed a marked decrease in expression within certain key metabolic pathways (such as the one-carbon pool by folate) in the NAFLD group, while expression in DNA repair-related pathways (such as non-homologous end joining) was significantly increased. Additionally, immune cell infiltration analysis showed significant differences in 19 immune cell types between the NAFLD and control groups, with 12 types exhibiting increased infiltration in the NAFLD group. Through protein-protein interaction (PPI) network analysis, we identified 41 critical intersecting genes, and ROC curve validation demonstrated that 25 of these genes had an AUC value exceeding 0.85, highlighting their potential as biomarkers for NAFLD in early diagnosis and personalized treatment in the future.This study identifies critical ferroptosis-related genes and immune cell infiltration differences in NAFLD, offering potential biomarkers for early diagnosis and personalized treatment.